Regulator to review safety concerns over medicines courier used by NHS

Regulator to review safety concerns over medicines courier used by NHS The care regulator has launched a review of serious and significant concerns raised by patients, clinicians and health groups about the safety and reliability of the services of Britain’s biggest medicines delivery business, the Guardian can reveal.

Sciensus is paid millions of pounds each year by the NHS to transport vital drugs and medical items to the homes of about 200,000 people with conditions including cancer, heart disease, diabetes, dementia and HIV.